Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro
- PMID: 6227421
- DOI: 10.1007/BF00254196
Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro
Abstract
The uptake of radiolabeled CLZ and CCNU by L1210 leukemia and murine bone marrow cells was investigated to determine whether the preferential ratio of alkylation of L1210 DNA to murine bone marrow DNA of 1.3 by 0.1 mM CLZ, as against a ratio of 0.6 by equimolar CCNU, is secondary to differences in uptake. The concentration of intact CLZ was determined in the medium and the intracellular water space. The cell: medium ratio (intracellular concentration/medium concentration) of CLZ in bone marrow cells was greater than that seen for L1210 cells. However, the intracellular CLZ concentration generally remained constant in both cell types at 37 degrees C, between 7.0 and 10.0 pmole/microliters. The L1210: murine bone marrow cell ratio of intracellular CLZ concentrations was approximately 1.0 from 10 to 60 min. The intracellular CCNU concentration during the uptake of 0.1 mM (chloroethyl-U-14C) CCNU at 37 degrees C was constant at 85 pmol/microliters from 10 to 60 min in L1210 cells, but slowly decreased from 66 pmole/microliters at 20 min to 43 pmole/microliters at 60 min in bone marrow cells. The L1210: murine bone marrow cell ratio of intracellular CCNU concentrations ranged from 1.45 to 1.98 from 20 to 60 min. Thus, it appears that the preferential ratio of alkylation of L1210 DNA to murine bone marrow DNA by CLZ compared with equimolar CCNU cannot be explained by differences in uptake of the two agents by the two cell types. The uptake of 0.1 mM CLZ at 37 degrees C by L1210 cells in McCoy's 5A medium containing 300 mg% glucose was not affected by the addition of 5 mM cold drug, nor was it affected by the absence of glucose in the medium, with or without cold drug. This suggests that CLZ uptake into L1210 cells is via passive diffusion and that CLZ does not enter these cells via the glucose transport mechanism.
Similar articles
-
Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.J Clin Invest. 1979 Oct;64(4):1103-11. doi: 10.1172/JCI109549. J Clin Invest. 1979. PMID: 158033 Free PMC article.
-
DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.Br J Cancer. 1985 Sep;52(3):377-82. doi: 10.1038/bjc.1985.204. Br J Cancer. 1985. PMID: 2931097 Free PMC article.
-
Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocin.Blood. 1984 Apr;63(4):759-67. Blood. 1984. PMID: 6322885
-
Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.Biochem Pharmacol. 1982 May 1;31(9):1671-9. doi: 10.1016/0006-2952(82)90667-0. Biochem Pharmacol. 1982. PMID: 7104031
-
Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.Cancer Res. 1982 Jul;42(7):2605-8. Cancer Res. 1982. PMID: 6211225
Cited by
-
Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.Cancer Chemother Pharmacol. 1985;14(2):156-9. doi: 10.1007/BF00434356. Cancer Chemother Pharmacol. 1985. PMID: 3971480
-
In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.Cancer Chemother Pharmacol. 1986;16(2):148-52. doi: 10.1007/BF00256165. Cancer Chemother Pharmacol. 1986. PMID: 3948300